Literature DB >> 23184959

Characterization of a novel α-conotoxin from conus textile that selectively targets α6/α3β2β3 nicotinic acetylcholine receptors.

Sulan Luo1, Dongting Zhangsun, Yong Wu, Xiaopeng Zhu, Yuanyan Hu, Melissa McIntyre, Sean Christensen, Muharrem Akcan, David J Craik, J Michael McIntosh.   

Abstract

α6β2 Nicotinic acetylcholine receptors (nAChRs) expressed by dopaminergic neurons in the CNS are potential therapeutic targets for the treatment of several neuropsychiatric diseases, including nicotine addiction and Parkinson disease. However, recent studies indicate that the α6 subunit can also associate with the β4 subunit to form α6β4 nAChRs that are difficult to pharmacologically distinguish from α6β2, α3β4, and α3β2 subtypes. The current study characterized a novel 16-amino acid α-conotoxin (α-CTx) TxIB from Conus textile whose sequence is GCCSDPPCRNKHPDLC-amide as deduced from gene cloning. The peptide and an analog with an additional C-terminal glycine were chemically synthesized and tested on rat nAChRs heterologously expressed in Xenopus laevis oocytes. α-CTx TxIB blocked α6/α3β2β3 nAChR with an IC(50) of 28 nm. In contrast, the peptide showed little or no block of other tested subtypes at concentrations up to 10 μm. The three-dimensional solution structure of α-CTx TxIB was determined using NMR spectroscopy. α-CTx TxIB represents a uniquely selective ligand for probing the structure and function of α6β2 nAChRs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23184959      PMCID: PMC3543038          DOI: 10.1074/jbc.M112.427898

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

1.  A novel mechanism of inhibition of high-voltage activated calcium channels by α-conotoxins contributes to relief of nerve injury-induced neuropathic pain.

Authors:  Harry Klimis; D J Adams; B Callaghan; S Nevin; P F Alewood; C W Vaughan; C A Mozar; M J Christie
Journal:  Pain       Date:  2011-02       Impact factor: 6.961

2.  The role of alpha6-containing nicotinic acetylcholine receptors in nicotine reward and withdrawal.

Authors:  K J Jackson; J M McIntosh; D H Brunzell; S S Sanjakdar; M I Damaj
Journal:  J Pharmacol Exp Ther       Date:  2009-07-30       Impact factor: 4.030

Review 3.  Role of α6 nicotinic receptors in CNS dopaminergic function: relevance to addiction and neurological disorders.

Authors:  Maryka Quik; Xiomara A Perez; Sharon R Grady
Journal:  Biochem Pharmacol       Date:  2011-06-13       Impact factor: 5.858

4.  Human alpha6 AChR subtypes: subunit composition, assembly, and pharmacological responses.

Authors:  A Kuryatov; F Olale; J Cooper; C Choi; J Lindstrom
Journal:  Neuropharmacology       Date:  2000-10       Impact factor: 5.250

5.  Atypical alpha-conotoxin LtIA from Conus litteratus targets a novel microsite of the alpha3beta2 nicotinic receptor.

Authors:  Sulan Luo; Kalyana Bharati Akondi; Dongting Zhangsun; Yong Wu; Xiaopeng Zhu; Yuanyan Hu; Sean Christensen; Cheryl Dowell; Norelle L Daly; David J Craik; Ching-I Anderson Wang; Richard J Lewis; Paul F Alewood; J Michael McIntosh
Journal:  J Biol Chem       Date:  2010-02-09       Impact factor: 5.157

6.  α-Conotoxin BuIA[T5A;P6O]: a novel ligand that discriminates between α6ß4 and α6ß2 nicotinic acetylcholine receptors and blocks nicotine-stimulated norepinephrine release.

Authors:  Layla Azam; Uwe Maskos; Jean-Pierre Changeux; Cheryl D Dowell; Sean Christensen; Mariella De Biasi; J Michael McIntosh
Journal:  FASEB J       Date:  2010-08-25       Impact factor: 5.191

7.  Nicotinic acetylcholine receptor subunits in rhesus monkey retina.

Authors:  Ji Liu; Alice M McGlinn; Alcides Fernandes; Ann H Milam; Christianne E Strang; Margot E Andison; Jon M Lindstrom; Kent T Keyser; Richard A Stone
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-10-24       Impact factor: 4.799

8.  Establishing regiocontrol of disulfide bond isomers of alpha-conotoxin ImI via the synthesis of N-to-C cyclic analogs.

Authors:  Christopher J Armishaw; Julie L Dutton; David J Craik; Paul F Alewood
Journal:  Biopolymers       Date:  2010       Impact factor: 2.505

Review 9.  Alpha-conotoxins as pharmacological probes of nicotinic acetylcholine receptors.

Authors:  Layla Azam; J Michael McIntosh
Journal:  Acta Pharmacol Sin       Date:  2009-05-18       Impact factor: 6.150

10.  Alpha-conotoxin MII-sensitive nicotinic acetylcholine receptors in the nucleus accumbens shell regulate progressive ratio responding maintained by nicotine.

Authors:  Darlene H Brunzell; Karen E Boschen; Elizabeth S Hendrick; Patrick M Beardsley; J Michael McIntosh
Journal:  Neuropsychopharmacology       Date:  2009-11-04       Impact factor: 7.853

View more
  27 in total

1.  Positional scanning mutagenesis of α-conotoxin PeIA identifies critical residues that confer potency and selectivity for α6/α3β2β3 and α3β2 nicotinic acetylcholine receptors.

Authors:  Arik J Hone; Miguel Ruiz; Mick'l Scadden; Sean Christensen; Joanna Gajewiak; Layla Azam; J Michael McIntosh
Journal:  J Biol Chem       Date:  2013-07-11       Impact factor: 5.157

2.  Characterization of a novel α-conotoxin TxID from Conus textile that potently blocks rat α3β4 nicotinic acetylcholine receptors.

Authors:  Sulan Luo; Dongting Zhangsun; Xiaopeng Zhu; Yong Wu; Yuanyan Hu; Sean Christensen; Peta J Harvey; Muharrem Akcan; David J Craik; J Michael McIntosh
Journal:  J Med Chem       Date:  2013-11-22       Impact factor: 7.446

Review 3.  Early engineering approaches to improve peptide developability and manufacturability.

Authors:  Jennifer L Furman; Mark Chiu; Michael J Hunter
Journal:  AAPS J       Date:  2014-10-23       Impact factor: 4.009

Review 4.  Human nicotinic receptors in chromaffin cells: characterization and pharmacology.

Authors:  Almudena Albillos; J Michael McIntosh
Journal:  Pflugers Arch       Date:  2017-10-20       Impact factor: 3.657

5.  A novel α4/7-conotoxin LvIA from Conus lividus that selectively blocks α3β2 vs. α6/α3β2β3 nicotinic acetylcholine receptors.

Authors:  Sulan Luo; Dongting Zhangsun; Christina I Schroeder; Xiaopeng Zhu; Yuanyan Hu; Yong Wu; Maegan M Weltzin; Spencer Eberhard; Quentin Kaas; David J Craik; J Michael McIntosh; Paul Whiteaker
Journal:  FASEB J       Date:  2014-01-07       Impact factor: 5.191

6.  α-Conotoxin [S9A]TxID Potently Discriminates between α3β4 and α6/α3β4 Nicotinic Acetylcholine Receptors.

Authors:  Yong Wu; Dongting Zhangsun; Xiaopeng Zhu; Quentin Kaas; Manqi Zhangsun; Peta J Harvey; David J Craik; J Michael McIntosh; Sulan Luo
Journal:  J Med Chem       Date:  2017-06-21       Impact factor: 7.446

7.  α-Conotoxin VnIB from Conus ventricosus is a potent and selective antagonist of α6β4* nicotinic acetylcholine receptors.

Authors:  Marloes van Hout; Amanda Valdes; Sean B Christensen; Phuong T Tran; Maren Watkins; Joanna Gajewiak; Anders A Jensen; Baldomero M Olivera; J Michael McIntosh
Journal:  Neuropharmacology       Date:  2019-06-28       Impact factor: 5.250

8.  α-Conotoxins Identify the α3β4* Subtype as the Predominant Nicotinic Acetylcholine Receptor Expressed in Human Adrenal Chromaffin Cells.

Authors:  Arik J Hone; J Michael McIntosh; Layla Azam; Jon Lindstrom; Linda Lucero; Paul Whiteaker; Juan Passas; Jesús Blázquez; Almudena Albillos
Journal:  Mol Pharmacol       Date:  2015-09-01       Impact factor: 4.436

9.  Molecular determinants of α-conotoxin potency for inhibition of human and rat α6β4 nicotinic acetylcholine receptors.

Authors:  Arik J Hone; Todd T Talley; Janet Bobango; Cesar Huidobro Melo; Fuaad Hararah; Joanna Gajewiak; Sean Christensen; Peta J Harvey; David J Craik; J Michael McIntosh
Journal:  J Biol Chem       Date:  2018-09-24       Impact factor: 5.157

Review 10.  Natural compounds interacting with nicotinic acetylcholine receptors: from low-molecular weight ones to peptides and proteins.

Authors:  Denis Kudryavtsev; Irina Shelukhina; Catherine Vulfius; Tatyana Makarieva; Valentin Stonik; Maxim Zhmak; Igor Ivanov; Igor Kasheverov; Yuri Utkin; Victor Tsetlin
Journal:  Toxins (Basel)       Date:  2015-05-14       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.